Anthos Therapeutics
MA - CambridgeBiotechnology
Focus: Anthos Therapeutics is a Cambridge-based antibody therapeutics company focused on cardiovascular disease. The company operates as a clinical-stage biotech with a lean pipeline centered on novel mechanisms.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Anthos Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Anthos Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
Atrial FibrillationClinical Trials (1)
NCT05421533Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
N/AHelp build intelligence for Anthos Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.